Bursa Announcements
Stock Name / Code :
DPHARMA ( 7148 )
Year :
2026
2025
2024
2023
2022
Archives
Select Date Range :
Categories :
Category
Additional Listing Announcement
Annual Audited Accounts
Annual Reports
Change of Corporate Information
Changes in Shareholdings
Circulars/Notice to Shareholders
Dealings in Listed Securities (Chapter 14 of Listing Requirements)
Delisting of Securities
Disclosure On Quarterly Production
Entitlements
Expiry / Maturity / Termination of Securities
Financial Results
General Announcement
General Meetings
Important Relevant Dates for Renounceable Rights
Investor Alert
IPO Announcement/LEAP Market Announcement
Listing Circulars
Listing Information and Profile
Prospectus
Reply to Query
Shares Buy Back
Special Announcements
Take-over Offer
Transfer of Listing
Unusual Market Activity
Filter
Reset
Thursday - 5 Mar 2026
MATERIAL LITIGATION
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Wednesday - 4 Mar 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - LEMBAGA TABUNG HAJI
Tuesday - 3 Mar 2026
Notice of Interest Sub. S-hldr (Section 137 of CA 2016) - LEMBAGA TABUNG HAJI
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Monday - 2 Mar 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Friday - 27 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
DPHARMA - Notice of Book Closure
Thursday - 26 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Second Interim Dividend
Quarterly rpt on consolidated results for the financial period ended 31 Dec 2025
OTHERS
Duopharma Biotech maintains robust revenue and profit growth momentum
MATERIAL LITIGATION
MATERIAL LITIGATION
KUALA LUMPUR HIGH COURT CIVIL SUIT NO. WA-22IP-15-02/2025 - WRIT OF SUMMONS AND STATEMENT OF CLAIM SERVED ON DUOPHARMA MANUFACTURING (BANGI) SDN. BHD. (A WHOLLY-OWNED SUBSIDIARY OF DUOPHARMA BIOTECH BERHAD) BY SUN PHARMACEUTICAL INDUSTRIES LIMITED
Wednesday - 25 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Friday - 20 Feb 2026
Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
«
1
2
3
4
5
6
7
8
9
10
»